Sculptra vs Radiesse — Two Biostimulators, Two Distinct Mechanisms, and Why the Difference Matters
Both treatments stimulate collagen. Both are described as biostimulators. Beyond that shared label, they work in fundamentally different ways — and understanding those differences is the starting point for using them well.
This is an extended review of our abridged general blog post Sculptra vs Radiesse
The problem with putting them in the same box
The term "biostimulator" has become a useful shorthand in aesthetic medicine for a category of treatments that work by stimulating the body's own collagen production rather than simply replacing lost volume with an injected substance.
Sculptra and Radiesse are the two most established members of that category, and they are frequently discussed as though they were essentially interchangeable; different brands offering the same biological effect through slightly different formulations. That framing is convenient but misleading.
The mechanisms by which these two treatments drive neocollagenesis are meaningfully different at a cellular and molecular level, and those differences have genuine clinical implications for patient selection, treatment planning, and the kind of result each is most likely to produce.
What Sculptra does and how it does it
Sculptra's active ingredient, poly-L-lactic acid (PLLA), is a synthetic, biocompatible polymer with a long history of medical use. When introduced into the tissue, PLLA microparticles do not provide immediate volume; they initiate a biological response. The mechanism of action of PLLA relies on the involvement of the immune system for neocollagenesis. For more information see our Sculptra Treatment page.
Recent studies have highlighted PLLA's propensity to elicit increased inflammatory cell response and activation of pro-inflammatory cytokines, particularly M1 and M2 macrophages, with confocal imaging providing insights into the formation of macrophage and giant cell capsules at the surface of PLLA particles, underscoring its immunostimulatory effects. Hamiltonfraser
In simpler terms: Sculptra works by triggering a controlled foreign body response. The immune system recognises the PLLA particles, mounts a managed inflammatory reaction, and in doing so activates the fibroblasts that produce collagen. The process is gradual, diffuse, and entirely dependent on that biological cascade unfolding at its own pace.
Results develop over months. The collagen produced is initially type III, maturing towards the more structurally robust type I over time. The result, when it arrives, is a broad and natural-looking improvement in facial volume and tissue quality that reflects genuine neocollagenesis.
What Radiesse does and how it does it differently
Radiesse is composed of calcium hydroxylapatite (CaHA) microspheres suspended in a carboxymethylcellulose carrier gel.
For further information see our Radiesse treatment page.
The mechanism of neocollagenesis it produces is distinctly different from Sculptra's inflammatory pathway. The data suggests the mechanism of action of CaHA represents a distinctly different mechanism compared to PLLA, with CaHA microspheres activating fibroblasts through direct contact rather than through immune-mediated inflammatory pathways. Hamiltonfraser
The CaHA microspheres act as a physical scaffold within the tissue. As the carrier gel is gradually absorbed over the first two to three months following injection, the microspheres remain and fibroblasts attach directly to their surface, stimulating collagen and elastin production through that direct cellular contact rather than through the inflammatory signalling cascade that PLLA relies upon.
Split-arm comparison of Sculptra and Radiesse shows similar rates of collagen formation but higher staining intensity for elastin fibres with CaHA, alongside an abundance of neovasculature in the deep dermis one month post-injection of CaHA. The additional angiogenic effect — the stimulation of new blood vessel formation — is a clinically interesting finding that may contribute to the quality and longevity of the tissue improvement Radiesse produces. Harley Clinic
Immediacy vs gradualism — the practical clinical distinction
Beyond the mechanistic difference, the most practically significant distinction between the two treatments is the timeline of their effects. Radiesse produces immediate visible correction from its carrier gel, with biostimulatory improvement building over the following months. Sculptra produces no immediate volumetric effect; results emerge gradually over three to six months and continue developing after the treatment course is complete.
This distinction has real implications for patient selection. A patient who needs visible improvement before a significant event in the next few weeks is not a Sculptra patient. One who is committed to a long-term investment in skin quality and structural restoration, and who understands and accepts the gradual timeline, is not necessarily a Radiesse patient either, but the choice between them is genuinely worth examining rather than defaulting to whichever happens to be more familiar.
The dilution question
The growing use of hyperdiluted Radiesse as a biostimulatory skin quality treatment deserves a specific mention, partly because the terminology around it is less settled than the practice itself. Whether a preparation is described as diluted or hyperdiluted is, as your treating clinician may tell you, a somewhat arbitrary distinction based on the ratio of product to diluent.
What matters clinically is that increasing dilution reduces the immediate volumetric effect of the carrier gel and shifts the balance of the treatment towards its biostimulatory mechanism. Hyperdiluted Radiesse is increasingly used for skin laxity, crepiness, and texture concerns in areas such as the neck, décolletage, and body, where the standard filler concentration would be inappropriate.
Sculptra does not have an equivalent dilution dynamic; its biostimulatory effect is the primary and only mechanism regardless of preparation.
Durability — how do they compare?
Radiesse results in its standard form typically last twelve to eighteen months; somewhat shorter than Sculptra, which produces results lasting eighteen to twenty-four months or more in many patients. The greater durability of Sculptra is consistent with its mechanism; the collagen produced through the sustained inflammatory and fibroblastic response that PLLA initiates tends to be more slowly degraded than the scaffold-mediated collagen produced by CaHA. That said, the immediate correction that Radiesse provides means that the patient experience over the first few months of treatment is very different, and not always comparable on a simple longevity basis.
Which suits which patient?
The honest answer is that patient selection for these two treatments is determined by a combination of clinical assessment, treatment goals, and the individual patient's relationship with time.
Sculptra suits the patient thinking in years rather than months; one who values a diffuse, natural-looking restoration of volume and tissue quality and who is comfortable with a gradual process.
Radiesse suits the patient who wants both immediate structural correction and sustained biostimulatory benefit, particularly in areas requiring definition and lift.
In practice, the two treatments are not competitors. They occupy different positions in a well-designed treatment plan, and for some patients, particularly those with both structural volume loss and broader skin quality concerns both have a role to play.
A note on reversibility
One practical point that deserves plain statement: neither Sculptra nor Radiesse can be dissolved in the way that hyaluronic acid fillers can. There is no equivalent of hyaluronidase for either product. Both are biocompatible and will be gradually absorbed by the body over time, but neither offers the safety net of immediate reversibility.
This is not a reason to avoid either treatment; it is a reason to ensure that whoever is delivering them has the clinical knowledge, the anatomical understanding, and the patient assessment skills to use them appropriately from the outset.
The views expressed in Clinical Perspectives are the author's own and reflect their personal and professional experience in aesthetic medicine.
References
McCarthy AD et al. A morphological analysis of calcium hydroxylapatite and poly-L-lactic acid biostimulator particles. Skin Research and Technology. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11163027/
Aguilera SB et al. Role of Calcium Hydroxylapatite (Radiesse) as a Regenerative Aesthetic Treatment: A Narrative Review. Aesthetic Surgery Journal. 2023;43(10):1063–1090. https://academic.oup.com/asj/article/43/10/1063/7249933
Waibel J et al. Comparative bulk RNA-Seq analysis of poly-L-lactic acid versus calcium hydroxylapatite reveals a novel, adipocyte-mediated regenerative mechanism of action unique to PLLA. Dermatologic Surgery.2024;50:S166–S171. https://pubmed.ncbi.nlm.nih.gov/?term=RNA-seq+PLLA+CaHA+Waibel
Nowag B et al. Calcium hydroxylapatite microspheres activate fibroblasts through direct contact to stimulate neocollagenesis. Journal of Cosmetic Dermatology. 2022;22(2):426–432.